Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketodex vs Ketofol for Prevention of Emergence Agitation in Nasal Surgeries
NCT04018157Phase 1Completed
- Sponsor
- Zagazig University
- Start
- Jul 2019
- Primary completion
- Nov 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of ketamine and dexmedetomidine in Emergence agitation (EA) (3 arms), sponsored by Zagazig University. Primary endpoints: The incidence of emergence agitation and The level of emergence agitation. Started Jul 2019; status: completed.
02
Drugs
ketaminedexmedetomidine
03
Conditions
Emergence agitation (EA)
Beyond the preview
Go deeper on NCT04018157.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04018157.